VMA21 Polyclonal Antibody
RD253204A
ApplicationsImmunoFluorescence, ELISA, ImmunoHistoChemistry
Product group Antibodies
ReactivityHuman, Mouse
TargetVMA21
Overview
- SupplierReddot Biotech
- Product NameVMA21 Polyclonal Antibody
- Delivery Days Customer5
- ApplicationsImmunoFluorescence, ELISA, ImmunoHistoChemistry
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration2.6 mg/ml
- ConjugateUnconjugated
- Gene ID203547
- Target nameVMA21
- Target descriptionvacuolar ATPase assembly factor VMA21
- Target synonymsMEAX; myopathy with excessive autophagy protein; vacuolar ATPase assembly integral membrane protein VMA21; VMA21 vacuolar H+-ATPase homolog; VMA21, vacuolar ATPase assembly factor; XMEA
- HostRabbit
- IsotypeIgG
- Scientific DescriptionThis gene encodes a chaperone for assembly of lysosomal vacuolar ATPase. Required for the assembly of the V0 complex of the vacuolar ATPase (V-ATPase) in the endoplasmic reticulum. Associates with the V0 complex of the vacuolar ATPase (V-ATPase). MEAX is a childhood-onset disease characterized by progressive vacuolation and atrophy of skeletal muscle. It is inherited in recessive fashion, affecting boys and sparing carrier females. Onset is in childhood, and patients exhibit weakness of the proximal muscles of the lower extremities, progressing slowly to involve other skeletal muscle groups over time.
- ReactivityHuman, Mouse
- Storage Instruction-20°C
- UNSPSC12352203